Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis

References

1. Ando H., Mitarai S., Kondo Y., Suetake T., Sekiguchi J. I., Kato S., Mori T., Kirikae T. 2010; Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan. Clin Microbiol Infect 16:1164–1168 [CrossRef]
   [Google Scholar]
2. Aubry A., Veziris N., Cambau E., Truffot-Pernot C., Jarlier V., Fisher L. M. 2006; Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis : functional analysis of mutant enzymes. Antimicrob Agents Chemother 50:104–112 [CrossRef]
   [Google Scholar]
3. Aziz M., Laszlo A., Raviglione M. C., Rieder H. L., Espinal M. A., Wright A. 2003 Guidelines for Surveillance of Drug Resistance in Tuberculosis Geneva: World Health Organization;
   [Google Scholar]
4. Caminero J. A. 2010; Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis 14:382–390
   [Google Scholar]
5. Conde M. B., Efron A., Loredo C., De Souza G. R., Graca N. P., Cezar M. C., Ram M., Chaudhary M. A., Bishai W. R. other authors 2009; Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 373:1183–1189 [CrossRef]
   [Google Scholar]
6. Fujiki A. 2001 TB Bacteriology Examination to Stop TB Tokyo: The Research Institute of Tuberculosis;
   [Google Scholar]
7. Guillemin I., Jarlier V., Cambau E. 1998; Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob Agents Chemother 42:2084–2088
   [Google Scholar]
8. Johnston J. C., Shahidi N. C., Sadatsafavi M., Fitzgerald J. M. 2009; Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE 4:e6914 [CrossRef]
   [Google Scholar]
9. Sekiguchi J., Miyoshi-Akiyama T., Augustynowicz-Kopec E., Zwolska Z., Kirikae F., Toyota E., Kobayashi I., Morita K., Kudo K. other authors 2007a; Detection of multidrug resistance in Mycobacterium tuberculosis . J Clin Microbiol 45:179–192 [CrossRef]
   [Google Scholar]
10. Sekiguchi J., Nakamura T., Miyoshi-Akiyama T., Kirikae F., Kobayashi I., Augustynowicz-Kopec E., Zwolska Z., Morita K., Suetake T. other authors 2007b; Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis strains. J Clin Microbiol 45:2802–2807 [CrossRef]
    [Google Scholar]
11. Sotgiu G., Ferrara G., Matteelli A., Richardson M. D., Centis R., Ruesch-Gerdes S., Toungoussova O., Zellweger J. P., Spanevello A. other authors 2009; Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 33:871–881 [CrossRef]
    [Google Scholar]
12. TRC 2007; Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002. Int J Tuberc Lung Dis 11:1129–1135
    [Google Scholar]
13. Van Deun A., Martin A., Palomino J. C. 2010a; Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int J Tuberc Lung Dis 14:131–140
    [Google Scholar]
14. Van Deun A., Maug A. K., Salim M. A., Das P. K., Sarker M. R., Daru P., Rieder H. L. 2010b; Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 182:684–692 [CrossRef]
    [Google Scholar]
15. Wang J. Y., Hsueh P. R., Jan I. S., Lee L. N., Liaw Y. S., Yang P. C., Luh K. T. 2006; Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. Thorax 61:903–908 [CrossRef]
    [Google Scholar]
16. Yew W. W., Lange C., Leung C. C. 2010; Treatment of tuberculosis update; 2010 Eur Respir J (in press). doi: 10.1183/09031936.00033010
17. Yoon Y. S., Lee H. J., Yoon H. I., Yoo C. G., Kim Y. W., Han S. K., Shim Y. S., Yim J. J. 2005; Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia. Int J Tuberc Lung Dis 9:1215–1219
    [Google Scholar]
18. Zhang Y., Telenti A. 2000 Genetics of Drug Resistance in Mycobacterium tuberculosis Washington, DC: American Society for Microbiology;
    [Google Scholar]